Low Back Pain
Low back pain (LBP) is a major social and economic problem. The prevalence of acute and chronic LBP in adults has doubled in the last decade and continues to grow rapidly in both men and women. LBP has a significant impact on the functional activity as it limits certain kinds of professional activity and is one of the main causes of disability. Given this, the diagnostic evaluation of patients with LBP can be very complex and requires special clinical decisions. When answering the questions about the causes of pain, choosing among several structures, which potentially involved in the formation of LBP, the key factors of this disease should be taken into account, because the wrong diagnosis can lead to therapeutic errors. Based on practical guidelines for the management of LBP, most international experts believe mandatory to use for LBP relief nonsteroidal anti-inflammatory drugs, which have strong analgesic effect and a strong anti-inflammatory action. We have analyzed a large number of clinical studies that confirm the effectiveness of lornoxicam and its benefits in the treatment of acute pain.
Full Text:PDF (Українська)
Cougot B., Petit A., Paget C. et al. Chronic low back pain among French healthcare workers and prognostic factors of return to work (RTW): a non-randomized controlled trial // J. Occup. Med. Toxicol. — 2015. — 10. — 40.
Shmagel A., Foley R., Ibrahim H. Epidemiology of chronic low back pain in US adults: National Health and Nutrition Examination Survey 2009–2010 // Arthritis Care Res. (Hoboken). — 2016. — 10. — 1002.
Juniper M., Le T.K., Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review // Expert Opin. Pharmacother. — 2009. — 10(16). — 2581-92.
Freburger J.K., Holmes G.M., Agans R.P. et al. The rising prevalence of chronic low back pain // Arch. Intern. Med. — 2009. — 169(3). — 251-8.
Katz J.N. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences // J. Bone Joint Surg. Am. — 2006. — 88 (Suppl. 2). — 21-4.
Gil Z., Smith D.B., Marouani N., Khafif A., Fliss D.M. Treatment of pain after head and neck surgeries: control of acute pain after head and neck oncological surgeries // Otolaryngology — Head Neck Surg. — 2006. — 135. — 182-188.
Analgesics Anti-inflammatory Drugs and Antipyretics // Martindale the complete drug reference / Ed. by S.C. Sweetman. — 36th ed. — London: Pharmaceutical Press, 2009. — Р. 4.
Karaman S., Gunusen I., Uyar M., Firat V. The effect of pre-operative lornoxicam and ketoprofen application on the morphine consumption of post-operative patient-controlled analgesia // J. Int. Med. Res. — 2006. — 34(2). — 168-175.
Herrmann W.A., Geertsen M.S. Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica/lumbo-sciatica: an analysis from a randomised, double-blind, multicentre, parallel-group study // Int. J. Clin. Pract. — 2009. — 63(11). — 1613-1621.
Norholt S.E., Sindet-Pedersen S., Larsen U. et al. Pain control after dental surgery: a double-blind, randomised trial of lornoxicam versus morphine // Pain. — 1996. — 67. — 335-343.
Sudip Kr. Das, M. Banerjee, S. Mondal, B. Ghosh A. Comparative Study of Efficacy and Safety of Lornoxicam Versus Tramadol as Analgesics After Surgery on Head and Neck // Indian J. Otolaryngol Head Neck Surg. — 2013 Jul. — 65(Suppl. 1). — 126-130.
Hillstrom C., Jakobsson J.G. Lornoxicam: pharmacology and usefulness to treat acute postoperative and musculoskeletal pain a narrative review // Expert Opin. Pharmacother. — 2013 Aug. — 14(12). — 1679-94.
- There are currently no refbacks.
Copyright (c) 2016 INTERNATIONAL NEUROLOGICAL JOURNAL
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2018